» Articles » PMID: 15900022

Modeling GFR Trajectories in Diabetic Nephropathy

Overview
Specialties Nephrology
Physiology
Date 2005 May 19
PMID 15900022
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

In an 8-year longitudinal study of Pima Indians with type 2 diabetes and nephropathy, we used statistical techniques that are novel and depend on minimal assumptions to compare longitudinal measurements of glomerular filtration rate (GFR). Individuals enrolled with new-onset microalbuminuria either progressed to macroalbuminuria (progressors, n = 13) or did not progress (nonprogressors, n = 13) during follow-up. Subjects with new-onset macroalbuminuria at screening were also followed (n = 22). Patients had their GFR determined serially by urinary iothalamate clearances (average 11 clearances; range 6-19). GFR courses of individuals were modeled using an adaptation of smoothing and regression cubic B-splines. Group comparisons were based on five-component vectors of fitted GFR values using a permutation approach to a Hotelling's T(2) statistic. GFR profiles of initially microalbuminuric progressors differed significantly from those of nonprogressors (P = 0.003). There were no significant baseline differences between progressors and nonprogressors with respect to any measured clinical parameters. The course of GFR in the first 4 yr following progression to macroalbuminuria in initially microalbuminuric subjects did not differ from that in newly screened macroalbuinuric subjects (P = 0.27). Without imposing simplifying models on the data, the statistical techniques used demonstrate that the courses of decline of GFR in definable subgroups of initially microalbuminuric diabetic Pima Indians, although generally progressive, follow distinct trajectories that are related to the extent of glomerular barrier dysfunction, as reflected by the evolution from microalbuminuria to macroalbuminuria.

Citing Articles

Anti-oxidant, anti-apoptotic, and protective effects of myricitrin and its solid lipid nanoparticle on streptozotocin-nicotinamide induced diabetic nephropathy in type 2 diabetic male mice.

Ahangarpour A, Oroojan A, Khorsandi L, Kouchak M, Badavi M Iran J Basic Med Sci. 2023; 26(8):851-853.

PMID: 37427321 PMC: 10329250. DOI: 10.22038/IJBMS.2023.22499.


American Indian chronic Renal insufficiency cohort study (AI-CRIC study).

Unruh M, Arzhan S, Feldman H, Looker H, Nelson R, Faber T BMC Nephrol. 2020; 21(1):291.

PMID: 32698776 PMC: 7376925. DOI: 10.1186/s12882-020-01954-y.


Markers and risk factors for chronic kidney disease in sub-Saharan Africans: baseline levels and 12-month trajectories in newly referred patients in Cameroon.

Patrice H, Pascal K, Francois K, Hilaire D, Solange D, Gloria A BMC Nephrol. 2020; 21(1):101.

PMID: 32188410 PMC: 7079528. DOI: 10.1186/s12882-020-01760-6.


Increased lipogenesis and impaired β-oxidation predict type 2 diabetic kidney disease progression in American Indians.

Afshinnia F, Nair V, Lin J, Rajendiran T, Soni T, Byun J JCI Insight. 2019; 4(21).

PMID: 31573977 PMC: 6948762. DOI: 10.1172/jci.insight.130317.


Patterns of progression of chronic kidney disease at later stages.

Caravaca-Fontan F, Azevedo L, Luna E, Caravaca F Clin Kidney J. 2018; 11(2):246-253.

PMID: 29644066 PMC: 5888389. DOI: 10.1093/ckj/sfx083.